Cargando…
CD24 expression is a marker for predicting clinical outcome and regulates the epithelial-mesenchymal transition in ovarian cancer via both the Akt and ERK pathways
The degree of peritoneal dissemination and chemotherapy-resistant tumors is related to the prognosis in patients with advanced-stage ovarian cancer. The epithelial-mesenchymal-transition (EMT) is a multifaceted pathological program that endows cancer cells with the ability to invade and disseminate....
Autores principales: | Nakamura, Kiyoko, Terai, Yoshito, Tanabe, Akiko, Ono, Yoshihiro J., Hayashi, Masami, Maeda, Kazuya, Fujiwara, Satoe, Ashihara, Keisuke, Nakamura, Michihiko, Tanaka, Yoshimichi, Tanaka, Tomohito, Tsunetoh, Satoshi, Sasaki, Hiroshi, Ohmichi, Masahide |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442399/ https://www.ncbi.nlm.nih.gov/pubmed/28440503 http://dx.doi.org/10.3892/or.2017.5583 |
Ejemplares similares
-
The efficacy of the cyclin-dependent kinase 4/6 inhibitor in endometrial cancer
por: Tanaka, Tomohito, et al.
Publicado: (2017) -
CD24 expression as a marker for predicting clinical outcome and invasive activity in uterine cervical cancer
por: TANAKA, TOMOHITO, et al.
Publicado: (2015) -
Pharmacokinetic evaluation and antitumor potency of liposomal nanoparticle encapsulated cisplatin targeted to CD24-positive cells in ovarian cancer
por: Ashihara, Keisuke, et al.
Publicado: (2020) -
The EMT (epithelial-mesenchymal-transition)-related protein expression indicates the metastatic status and prognosis in patients with ovarian cancer
por: Takai, Masaaki, et al.
Publicado: (2014) -
Gemcitabine as a molecular targeting agent that blocks the Akt cascade in platinum-resistant ovarian cancer
por: Kawaguchi, Hiroshi, et al.
Publicado: (2014)